Articles/ Rare diseases/ Views and analysis Tunnah’s musings: Rare diseases hold key to future of drug development Linda Banks Cambridge Rare Disease Network, CRDN, genomes, patients, pharma, Rare diseases 0 Comment The lessons that can be learned for the future of drug development from the collaboration and innovation in this space. Share X Tunnah’s musings: Rare diseases hold key to future of drug development https://pharmaphorum.com/views-and-analysis/tunnahs-musings-rare-diseases-hold-key-future-drug-development/
Articles/ Healthcare/ UK & Europe/ Views and analysis Rethinking rare diseases: treat the whole patient Marco Ricci CRDN, patient centricity, patients, rare disease 0 Comment CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry. Share X Rethinking rare diseases: treat the whole patient https://pharmaphorum.com/views-and-analysis/rethinking-rare-diseases-treat-whole-patient/